The roots of Lupos (Canada) Biotechnology Inc. go back to 2013, but it wasn't until 2017 that the company became licensed by Health Canada under the Narcotics Act. On transition to The Cannabis Act in October 2018, Lupos obtained the following licenses:

Standard Processing and Research. We continue to operate under these licenses today as a provider of cannabis consumer products.

Our vision is to deliver the highest added value supply chain services to players large and small across the burgeoning Canadian cannabis industry excelling in:

- Distillate Sales 

- Extraction Tolling programmes

- Topical Category Contract Manufacturing

We are, first and foremost, good corporate citizens. We want to support the legal cannabis industry and maintain compliance with all regulatory and legal requirements. Our interest in the market is focused on the positive health and wellness potential of cannabis and our business decisions are guided by this focus. We are committed to operating with transparency and integrity while treating our stakeholders and the environment with respect.